XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Revenues $ 137,430 $ 106,786
Operating Expenses    
Cost of sales (excluding depreciation and amortization) 49,157 37,708
Research and development 10,511 5,924
Selling, general, and administrative 48,021 36,468
Depreciation and amortization 14,686 14,700
Contingent consideration fair value adjustment 90 961
Restructuring activities 0 1,130
Gain on sale of building (5,347) 0
Total Operating Expenses, net 117,118 96,891
Operating Income 20,312 9,895
Other Income (Expense), net    
Unrealized gain on investment in equity securities 9,655 0
Interest expense, net (4,600) (7,696)
Other expense, net (32) (34)
Income Before Income Tax Expense 25,335 2,165
Income tax expense 7,128 726
Net Income 18,207 1,439
Dividends on Series A Convertible Preferred Stock (406) (406)
Net Income Available to Common Shareholders $ 17,801 $ 1,033
Basic and Diluted Income Per Share:    
Basic Income (Loss) Per Share (in dollars per share) $ 0.84 $ 0.06
Diluted Income (Loss) Per Share (in dollars per share) $ 0.82 $ 0.06
Basic Weighted-Average Shares Outstanding (in shares) 19,099 16,392
Diluted Weighted-Average Shares Outstanding (in shares) 19,422 16,531